Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methylbutyl)-5-(2-methyl-1-oxopropyl)-6-(4-methylpentyl)-, (1R,5S,6R,7S)- (11079-55-3)

Identification
Name:	Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methylbutyl)-5-(2-methyl-1-oxopropyl)-6-(4-methylpentyl)-, (1R,5S,6R,7S)-
CAS:	11079-55-3
Molecular Formula:	C₃₅H₆₀O₄
Molecular Structure:
Properties
Safety Data

Other Product

Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-penten-1-yl)-,(1R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methyl-2-butenyl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-pentenyl)-, (1R,5S,6R,7S)-, compd. withN-cyclohexylcyclohexanamine (1:1)
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methyl-2-butenyl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-pentenyl)-, sodium salt, (1R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-methoxy-6-methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-penten-1-yl)-,(1R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxobutyl)-6-(4-methyl-3-penten-1-yl)-,(1R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,5-(3,4- dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-3,- 7-bis(3-methyl-2-butenyl)-1-[(2R)-5- methyl-2-(1-methylethenyl)-4-hexenyl]-,(1R,5S,7S)-rel-(-)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,6-(3,4-dihydroxyphenyl)-4,7-dihydroxy-, (1R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,5-benzoyl-1-[(4,4-dimethyl-2-methylenecyclohexyl)methyl]-4-hydroxy-6,6-dimethyl-3,7-bis(3-methyl-2-butenyl)-, (1R,5S)-rel-
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-8-methyl-5,7-bis(3-methyl-2-buten-1-yl)-1-(2-methyl-1-oxopropyl)-8-(4-methyl-3-penten-1-yl)-,(1R,5R,7S,8R)-
Bicyclo[3.3.1]nonane-2,4,9-trione,6-methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-penten-1-yl)-3-[[(4aS,5R,8R,8aS)-3,4,4a,5,6,7,8,8a-octahydro-5-hydroperoxy-5-methyl-8-(1-methylethyl)-2-naphthalenyl]methyl]-,(1R,3R,5S,6R,7S)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methyl-2-buten-1-yl)-5-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-,(1S,5S,7S)-
2-Oxa-4-azabicyclo[3.3.1]non-3-ene,8-bromo-6-[(phenylmethoxy)methyl]-3-(trifluoromethyl)-,(1R,5S,6R,8R)-rel-
2-Oxa-4-azabicyclo[3.3.1]non-3-ene,8-bromo-6-[(phenylmethoxy)methyl]-3-(trifluoromethyl)-,(1R,5S,6R,8S)-rel-
Bicyclo[3.2.1]oct-3-ene-2,8-dione,7-(4-hydroxy-3-methoxyphenyl)-5-methoxy-6-methyl-3-(2-propen-1-yl)-,(1R,5R,6R,7R)-
(1R,5S)-9-cyclopropyl-7-[4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl]-3-[(2,3-dimethylphenyl)methyl]-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxamide,methanesulfonic acid
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-5,7-bis[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-4-hydroxy-8,8-dimethyl-1-(3-methyl-2-buten-1-yl)-,(1R,5R,7S)-rel-(-)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,3-(3,4-dihydroxybenzoyl)-4-hydroxy-8-methyl-1,5,7-tris(3-methyl-2-buten-1-yl)-8-(4-methyl-3-penten-1-yl)-,(1R,5R,7R,8S)-rel-(+)-
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-3-(4-hydroxy-3-methoxybenzoyl)-8,8-dimethyl-1,7-bis(3-methyl-2-butenyl)-5-[(2S)-5-methyl-2-(1-methylethenyl)-4-hexenyl]-,(1R,5R,7R)-
Bicyclo[3.3.1]non-2-ene-1-carboxylic acid,3-methyl-7-methylene-9-oxo-, methyl ester
2-Pyrrolidineacetamide,4-[(2E,4E,6R)-6-[(1R,2'R,3R,4S,5R)-1,4-dimethylspiro[2,9-dioxabicyclo[3.3.1]non-6-ene-8,2'-oxiran]-3-yl]-1-hydroxy-4-methyl-2,4-heptadien-1-ylidene]-N,a-dimethyl-3,5-dioxo-1-[(2S,5S,6S)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]-,ion(1-), (aS,2S,4E)-